NYKODE THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.49 NOK | -1.32% |
|
-11.77% | -36.96% |
| 06-20 | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting | CI |
| 06-11 | Nykode Therapeutics ASA Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NYKODE THERAPEUTICS | Bio Therapeutic Drugs | -1.32% | -11.77% | -36.96% | -47.35% | - | 423M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NYKD Stock
- Charts Nykode Therapeutics
- Comparison Chart
